The association between CLCN3 (Cl-/H+ Antiporter 3) and Neurodevelopmental Disorder With Seizures And Brain Abnormalities is well established and manually curated, with its 2 contributing sources — 2 of them expert-curated — recording a known molecular basis and pathogenic variants.
Sources2
Clinical variants4
Symptoms40
Compounds0
Trials0
Publications1
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.